JPH06169761A - Culture medium for serum-free culture of fibroblast derived from animal and method for culturing - Google Patents
Culture medium for serum-free culture of fibroblast derived from animal and method for culturingInfo
- Publication number
- JPH06169761A JPH06169761A JP4351019A JP35101992A JPH06169761A JP H06169761 A JPH06169761 A JP H06169761A JP 4351019 A JP4351019 A JP 4351019A JP 35101992 A JP35101992 A JP 35101992A JP H06169761 A JPH06169761 A JP H06169761A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- serum
- culture
- added
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
(57)【要約】
【目的】 無血清条件下において、血清添加時と同程度
の動物由来線維芽細胞の増殖を得るための、無血清培養
用培地及び培養方法を提供する。
【構成】 MCDB153培地を基礎培地とし、これに
カルシウムイオンを1.8mM以上、及びマグネシウム
イオンを0.8〜1.2mM添加して、無血清培養用培
地とする。この培地を用いて、動物由来線維芽細胞の初
代培養及び継代培養を行うことができる。
(57) [Summary] [Object] To provide a serum-free culture medium and a culture method for obtaining the proliferation of animal-derived fibroblasts at the same level as in the addition of serum under serum-free conditions. [Structure] MCDB153 medium is used as a basal medium, to which calcium ion of 1.8 mM or more and magnesium ion of 0.8 to 1.2 mM are added to obtain a serum-free culture medium. Using this medium, primary culture and subculture of animal-derived fibroblasts can be performed.
Description
【0001】[0001]
【産業上の利用分野】本発明は、動物由来線維芽細胞の
良好な無血清培養用培地及び培養方法に関し、線維芽細
胞に及ぼす種々の因子の影響を的確に解析するのに最適
な培養系を提供するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a good serum-free culture medium for animal-derived fibroblasts and a culture method, which is an optimal culture system for accurately analyzing the influence of various factors on fibroblasts. Is provided.
【0002】[0002]
【従来の技術】従来、動物由来線維芽細胞の培養は、イ
ーグルのMEM培地のようにアミノ酸類にビタミン類等
を添加した基礎培地に、ウシ胎児,子ウシ等動物の血清
を添加して行われてきた。2. Description of the Related Art Conventionally, animal-derived fibroblasts have been cultured by adding animal serum such as fetal calf and calf to a basal medium prepared by adding vitamins to amino acids like MEM medium of Eagle. I've been told.
【0003】また最近では、動物の血清を添加せず、そ
の替わりに細胞成長因子,細胞接着因子,担体タンパク
質,抗酸化剤,タンパク分解酵素阻害剤等を添加して培
養を行う試みがなされている。たとえばヒト線維芽細胞
の無血清培養用として、RITC80−7,MCDB系
列,HamF−12・DME1:1混合培地等を基礎培
地とし、細胞成長因子としてインシュリン,EGF(Ep
idermal Growth Factor),PDGF(Platelet-Derive
d Growth Factor),bFGF(basic Fibroblast Grow
th Factor)を、担体タンパク質としてトランスフェリ
ン等を、細胞接着因子としてフィブロネクチンを添加し
た培地が開発されている。In recent years, attempts have been made to culture without adding animal serum, but instead adding cell growth factors, cell adhesion factors, carrier proteins, antioxidants, protease inhibitors and the like. There is. For example, for serum-free culture of human fibroblasts, RITC80-7, MCDB series, HamF-12 / DME 1: 1 mixed medium and the like are used as basal medium, and insulin and EGF (Ep (Ep) are used as cell growth factors.
idermal Growth Factor, PDGF (Platelet-Derive)
d Growth Factor), bFGF (basic Fibroblast Grow)
th Factor), transferrin etc. as a carrier protein, and fibronectin as a cell adhesion factor have been developed.
【0004】[0004]
【発明が解決しようとする課題】しかし、上記の技術の
うち、血清を添加した培地を用いる培養方法では、血清
中に多くの物質が含まれており、それらの作用も複雑多
岐にわたるため、また血清のロット差が激しいため、線
維芽細胞の性状や生理,薬物の影響などについての実験
結果の解析に困難をきたしていた。However, among the above techniques, in the culture method using a medium to which serum is added, since many substances are contained in the serum and their actions are complicated and diversified, Due to the large difference in serum lots, it was difficult to analyze the experimental results regarding the properties and physiology of fibroblasts, the influence of drugs and the like.
【0005】また、無血清条件下での培養方法において
も、血清添加時と同レベルの増殖を得ることはなかなか
困難であり、増殖を良くするためには基礎培地に種々の
成分を添加する必要があり、薬物等の作用を解析するに
はやはり支障となっていた。Further, even in a culture method under serum-free conditions, it is difficult to obtain the same level of growth as when adding serum, and it is necessary to add various components to the basal medium in order to improve the growth. However, it still hinders the analysis of the action of drugs and the like.
【0006】[0006]
【課題を解決するための手段】そこで、われわれは、基
礎培地に対して添加成分の種類及び量をなるべく少なく
した動物由来線維芽細胞の培養系を確立することを検討
した。その結果、基礎培地として高アミノ酸培地である
MCDB153培地を用い、これに1.8mM以上のカ
ルシウムイオンと、0.8〜1.2mMのマグネシウム
イオンといった単純な無機イオンを添加した系で、良好
な線維芽細胞の増殖が得られることを見い出し、本発明
を完成するに至った。[Means for Solving the Problems] Therefore, we studied to establish a culture system for animal-derived fibroblasts in which the types and amounts of the components added to the basal medium were reduced as much as possible. As a result, the MCDB153 medium, which is a high amino acid medium, was used as the basal medium, and a system in which simple inorganic ions such as calcium ion of 1.8 mM or more and magnesium ion of 0.8 to 1.2 mM were added to the medium were favorable. The inventors have found that fibroblast proliferation can be obtained, and completed the present invention.
【0007】添加するカルシウムイオンの量としては、
1.8mM以上が適当である。図1に、基本培地MCD
B153培地に対し、マグネシウムイオン添加量を1.
0mMとし、カルシウムイオンの添加量を0.1mM〜
1.8mMの範囲で添加した場合のヒト線維芽細胞の増
殖のようすを示した。この図から、血清添加時と同レベ
ルの増殖を得るには、カルシウムイオンは1.8mM添
加する必要があることが認められる。The amount of calcium ion added is
1.8 mM or more is suitable. Figure 1 shows the basal medium MCD
The amount of magnesium ion added to the B153 medium was 1.
0 mM, and the addition amount of calcium ion is 0.1 mM
The figure shows the growth of human fibroblasts when added in the range of 1.8 mM. From this figure, it is recognized that 1.8 mM of calcium ion needs to be added in order to obtain the same level of proliferation as when serum was added.
【0008】一方、マグネシウムイオンの添加量は0.
8〜1.2mMが適当である。図2に、MCDB153
培地に対し、カルシウムイオン添加量を1.8mMと
し、マグネシウムイオンの添加量を0.5〜1.5mM
の範囲で添加した場合のヒト線維芽細胞の増殖のようす
を示した。この図から明らかなように、0.8mM未満
のマグネシウムイオン添加では十分な増殖が得られず、
1.2mM以上の添加ではかえって線維芽細胞の増殖を
阻害するため、好ましくない。On the other hand, the amount of magnesium ion added is 0.
8 to 1.2 mM is suitable. In FIG. 2, MCDB153
The amount of calcium ion added to the medium was 1.8 mM, and the amount of magnesium ion added was 0.5 to 1.5 mM.
It shows the growth of human fibroblasts when added in the range. As is clear from this figure, sufficient growth was not obtained with the addition of less than 0.8 mM magnesium ion,
The addition of 1.2 mM or more rather inhibits the proliferation of fibroblasts and is not preferable.
【0009】なお、本発明に係る培地に、EGFやイン
シュリンを添加すると、一層細胞の増殖を促進すること
ができる。The addition of EGF or insulin to the medium of the present invention can further promote cell growth.
【0010】[0010]
【作用】以上のように、MCDB153培地を基礎培地
とし、カルシウムイオンを1.8mM以上、及びマグネ
シウムイオンを0.8〜1.2mM添加した培地におい
て、ヒトをはじめ動物の各組織由来の線維芽細胞を無血
清条件下で培養すると、図1に示すように、血清添加時
と同程度の増殖を得ることができる。ヒト皮膚線維芽細
胞の培養の場合、培養2日後から細胞数は急増し、血清
添加時とほとんど同様の増殖曲線が得られる。As described above, MCDB153 medium is used as the basal medium, and calcium ion of 1.8 mM or more and magnesium ion of 0.8 to 1.2 mM are added to the medium, and fibroblasts derived from various tissues of humans and animals are derived. When cells are cultured under serum-free conditions, as shown in FIG. 1, it is possible to obtain the same level of proliferation as when serum is added. In the case of culturing human skin fibroblasts, the number of cells rapidly increases after 2 days of culturing, and almost the same growth curve as that when serum was added can be obtained.
【0011】なお、本発明に係る培地及び培養方法は、
線維芽細胞の初代培養,継代培養のいずれにおいても用
いることができ、良好な結果が得られる。The medium and culture method according to the present invention are
It can be used in both primary culture and subculture of fibroblasts, and good results are obtained.
【0012】[0012]
【実施例】さらに本発明について、実施例により詳細に
説明する。EXAMPLES The present invention will be described in more detail with reference to Examples.
【0013】まず本発明の実施例として、ヒト皮膚線維
芽細胞の無血清培養用培地の組成を表1に示す。この培
地のカルシウムイオン添加量は1.8mM、マグネシウ
ムイオン添加量は0.98mMである。First, as an example of the present invention, Table 1 shows the composition of a serum-free culture medium for human dermal fibroblasts. The amount of calcium ions added to this medium was 1.8 mM, and the amount of magnesium ions added was 0.98 mM.
【表1】 [Table 1]
【0014】上記培地を用い、ヒト線維芽細胞の初代培
養を行った。方法は以下の通りである。Human fibroblasts were primarily cultured using the above medium. The method is as follows.
【0015】採取したヒト皮膚組織をリン酸緩衝塩類溶
液(PBS(-))で洗浄後、PBS(-)液中で細かく切断
する。次いで数回PBS(-)で洗い、細切片とし、0.
1mg/mlトリプシン,0.02%EDTA液で30
分間処理し、ろ過後ろ液を1000rpm,5分間遠心
して、細胞ペレットを得、2〜3度遠心分離を繰り返し
てトリプシンを除去する。ついで細胞ペレットを培養液
に懸濁する。The collected human skin tissue is washed with a phosphate buffered saline solution (PBS (-)) and then finely cut in the PBS (-) solution. Then, it was washed several times with PBS (-) to make fine slices, and
1 mg / ml trypsin, 30 with 0.02% EDTA solution
After treatment for 1 minute, the solution after filtration is centrifuged at 1000 rpm for 5 minutes to obtain a cell pellet, and centrifugation is repeated 2-3 times to remove trypsin. The cell pellet is then suspended in the culture medium.
【0016】一方、フィブロネクチンをPBS(-)で1
0μg/mlとなるように希釈し、シャーレに重層す
る。37℃で30分間静置し、フィブロネクチン液を吸
引除去し、PBS(-)で2回洗浄する。本発明に係る培
地を添加した後約100万個の上記分離細胞を添加し、
炭酸ガス培養器にて2〜3時間培養し、非接着細胞と組
織の残さを吸引除去する。続いて新たに培地を加え、酸
素-炭酸ガス培養器に移し、さらに培養を続けた。On the other hand, 1% of fibronectin with PBS (-)
Dilute to 0 μg / ml and overlay on a petri dish. The mixture is allowed to stand at 37 ° C. for 30 minutes, the fibronectin solution is removed by suction, and washed twice with PBS (−). After adding the medium according to the present invention, adding about 1 million of the above isolated cells,
After culturing for 2 to 3 hours in a carbon dioxide incubator, the non-adherent cells and the residue of the tissue are removed by suction. Subsequently, a new medium was added, the medium was transferred to an oxygen-carbon dioxide incubator, and the culture was further continued.
【0017】この際、培養用培地として、DMEM培地
に10%子ウシ血清を加えたものを用いて同様に培養し
た場合を比較例1、MCDB153培地に0.1mMカ
ルシウムイオン及び0.1mMマグネシウムイオンを加
えたものを用いて、同様に培養した場合を比較例2とし
た。At this time, the same culture was carried out using DMEM medium supplemented with 10% calf serum as the culture medium, and Comparative Example 1 was used. MCDB153 medium was supplemented with 0.1 mM calcium ion and 0.1 mM magnesium ion. The case of culturing in the same manner as that of Comparative Example 2 was used.
【0018】本実施例における線維芽細胞の増殖のよう
すを図3に示す。培養開始後、接着性の線維芽細胞は2
万個程度であったが、2日後には約3万個となり、その
後急激に増殖して6日後には12万個に達し、血清を添
加した比較例1と同程度の増殖が認められた。一方、カ
ルシウムイオン,マグネシウムイオンの濃度が低い比較
例2では、8日間培養してもほとんど線維芽細胞の増殖
は認められなかった。The manner of proliferation of fibroblasts in this example is shown in FIG. After the start of culture, the number of adhesive fibroblasts was 2
Although the number was about 10,000, it increased to about 30,000 after 2 days, then rapidly increased to 120,000 after 6 days, and the same level of proliferation as in Comparative Example 1 to which serum was added was observed. . On the other hand, in Comparative Example 2 in which the concentration of calcium ions and magnesium ions was low, almost no proliferation of fibroblasts was observed even after culturing for 8 days.
【0019】[0019]
【発明の効果】以上のように、本発明により、無血清条
件下、なるべく添加成分の種類と添加量を少なくして、
動物由来の線維芽細胞を特異的且つ効率良く培養するこ
とが可能となった。As described above, according to the present invention, it is possible to reduce the types and amounts of the added components under serum-free conditions as much as possible.
It has become possible to specifically and efficiently culture animal-derived fibroblasts.
【図1】線維芽細胞の無血清培養において、カルシウム
イオンの影響を示す図である。FIG. 1 is a diagram showing the effect of calcium ions in serum-free culture of fibroblasts.
【図2】線維芽細胞の無血清培養において、マグネシウ
ムイオンの影響を示す図である。FIG. 2 is a diagram showing the influence of magnesium ions in serum-free culture of fibroblasts.
【図3】本発明の実施例及び比較例1,2の増殖の違い
を示す図である。FIG. 3 is a diagram showing a difference in proliferation between the example of the present invention and Comparative examples 1 and 2.
1 DMEM培地に10%子ウシ血清を添加した場合 2 MCDB153培地に、1.8mMカルシウムイオ
ン及び1.0mMマグネシウムイオンを添加した場合 3 MCDB153培地に、1.0mMカルシウムイオ
ン及び1.0mMマグネシウムイオンを添加した場合 4 MCDB153培地に、0.1mMカルシウムイオ
ン及び1.0mMマグネシウムイオンを添加した場合 5 実施例1 6 比較例1 7 比較例21 When 10% calf serum was added to DMEM medium 2 When MCDB153 medium was added with 1.8 mM calcium ion and 1.0 mM magnesium ion 3 MCDB153 medium was added with 1.0 mM calcium ion and 1.0 mM magnesium ion When added 4 When added 0.1 mM calcium ion and 1.0 mM magnesium ion to MCDB153 medium 5 Example 1 6 Comparative example 1 7 Comparative example 2
Claims (2)
ルシウムイオンを1.8mM以上、及びマグネシウムイ
オンを0.8〜1.2mM添加して成る、動物由来線維
芽細胞の無血清培養用培地。1. A medium for serum-free culture of animal-derived fibroblasts, which comprises MCDB153 medium as a basal medium and calcium ions of 1.8 mM or more and magnesium ions of 0.8 to 1.2 mM are added.
ンを1.8mM以上と、マグネシウムイオンを0.8〜
1.2mMとを添加して、無血清条件下で培養すること
を特徴とする、動物由来線維芽細胞の無血清培養方法。2. A MCDB153 medium containing calcium ions in an amount of 1.8 mM or more and magnesium ions in an amount of 0.8 to 0.8.
1.2 mM, and a serum-free culture method of animal-derived fibroblasts, which comprises culturing under serum-free conditions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4351019A JPH06169761A (en) | 1992-12-04 | 1992-12-04 | Culture medium for serum-free culture of fibroblast derived from animal and method for culturing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4351019A JPH06169761A (en) | 1992-12-04 | 1992-12-04 | Culture medium for serum-free culture of fibroblast derived from animal and method for culturing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06169761A true JPH06169761A (en) | 1994-06-21 |
Family
ID=18414491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4351019A Pending JPH06169761A (en) | 1992-12-04 | 1992-12-04 | Culture medium for serum-free culture of fibroblast derived from animal and method for culturing |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06169761A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916809A (en) * | 1996-03-22 | 1999-06-29 | Nec Corporation | Medium for culturing normal human epidermal melanocytes |
| EP0845963A4 (en) * | 1995-07-28 | 2000-11-02 | Isolagen Technologies Inc | The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| WO2015098111A1 (en) * | 2013-12-26 | 2015-07-02 | 国立大学法人広島大学 | METHOD FOR ESTABLISHING iPS CELLS AND METHOD FOR LONG-TERM MAINTENANCE OF STEM CELLS |
| JP2015123079A (en) * | 2013-12-26 | 2015-07-06 | 国立大学法人広島大学 | METHOD FOR ESTABLISHING iPS CELLS, AND METHOD FOR LONG-TERM MAINTENANCE OF STEM CELLS |
| CN116396928A (en) * | 2023-05-12 | 2023-07-07 | 细新(上海)医疗科技有限公司 | Culture system, culture method and application of primary fibroblast |
-
1992
- 1992-12-04 JP JP4351019A patent/JPH06169761A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0845963A4 (en) * | 1995-07-28 | 2000-11-02 | Isolagen Technologies Inc | The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| EP1358857A1 (en) * | 1995-07-28 | 2003-11-05 | Isolagen International S.A. | The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| CN100349556C (en) * | 1995-07-28 | 2007-11-21 | 埃索拉根技术有限公司 | Using autologous dermal fibroblasts to repair skin and soft tissue defects |
| US5916809A (en) * | 1996-03-22 | 1999-06-29 | Nec Corporation | Medium for culturing normal human epidermal melanocytes |
| WO2015098111A1 (en) * | 2013-12-26 | 2015-07-02 | 国立大学法人広島大学 | METHOD FOR ESTABLISHING iPS CELLS AND METHOD FOR LONG-TERM MAINTENANCE OF STEM CELLS |
| JP2015123079A (en) * | 2013-12-26 | 2015-07-06 | 国立大学法人広島大学 | METHOD FOR ESTABLISHING iPS CELLS, AND METHOD FOR LONG-TERM MAINTENANCE OF STEM CELLS |
| CN116396928A (en) * | 2023-05-12 | 2023-07-07 | 细新(上海)医疗科技有限公司 | Culture system, culture method and application of primary fibroblast |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peehl et al. | Growth and differentiation of human keratinocytes without a feeder layer or conditioned medium | |
| US5888816A (en) | Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells | |
| Tiggelman et al. | Collagen synthesis by human liver (myo) fibroblasts in culture: evidence fora regulatory role of IL-1β, IL-4, TGFβ and IFN gamma | |
| US4940666A (en) | Process and defined medium for growth of human epidermal keratinocyte cells | |
| US5866167A (en) | Non-viable total keratinocyte lysate for promoting wound healing | |
| US7109032B2 (en) | Serum-free medium for mesenchymal stem cells | |
| CN101203601B (en) | Transplantation of Differentiated Immature Adipocytes and Biodegradable Scaffolds for Tissue Population | |
| US20060110825A1 (en) | Process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cell obtainable by this process | |
| EP2368974A1 (en) | Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof | |
| US7037721B1 (en) | Protein-free defined media for the growth of normal human keratinocytes | |
| CN105267243B (en) | Stem cell extract for eliminating skin striae gravidarum | |
| EP0953633A1 (en) | Cell culturing method and medium for producing proliferated, normal, differentiated human liver cells | |
| WO2006005977A1 (en) | Novel method for culturing keratinocytes, melanocytes and fibroblasts for skin grafting | |
| CN114752554A (en) | A serum-free myogenic differentiation medium containing natural compounds and its application | |
| CN117625519B (en) | Fetal bovine serum-free culture medium for promoting survival and proliferation of muscle stem cells in vitro and its application | |
| CN111956668A (en) | Skin regeneration and repair cell composition and preparation method thereof | |
| JP7526405B2 (en) | Method for isolating and mass-producing hair papilla cells derived from scalp tissue | |
| EP0350887A2 (en) | Serum-free medium and process for cultivating mammalian cells | |
| EP1337624B1 (en) | Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof | |
| US6008047A (en) | Cell culturing method and medium | |
| CN114480272A (en) | Additive and culture medium for umbilical cord mesenchymal stem cell culture and preparation method of additive and culture medium | |
| JPH0732706B2 (en) | Hair mother cell culture method | |
| CN114276986A (en) | A method for separating and purifying buffalo primary myoblasts and its application | |
| JPS63304978A (en) | Method for breeding epithelial cell | |
| JP2022140224A (en) | Method of preparing freeze-dried stem cell powder |